Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency
Ukraine experiences one of the most severe HIV epidemics in Europe. This policy brief is a result of a team effort involving the State Institution Ukrainian Center for Socially Dangerous Disease Control of the MOH of Ukraine, and international part...
| Main Author: | |
|---|---|
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2016
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2016/01/26411947/value-money-ukraine’s-hiv-response-strategic-investment-improved-efficiency http://hdl.handle.net/10986/24769 |
| Summary: | Ukraine experiences one of the most
severe HIV epidemics in Europe. This policy brief is a
result of a team effort involving the State Institution
Ukrainian Center for Socially Dangerous Disease Control of
the MOH of Ukraine, and international partners. The study
was part of the regional initiatives on HIV allocative
efficiency analysisi and funded and technically supported by
the World Bank and UNAIDS. We greatly acknowledge the
contributions of all the team members, stakeholders and
other partners. There are major opportunities, but also
major risks in relation to HIV investment decisions in
Ukraine in the coming five years. While decreasing funding
would lead to a marked increase in deaths, new infections
and future health care costs, a smart approach to increasing
HIV investment, could avert around half of the new
infections and deaths up to 2030 compared to business as
usual. The keys to success are (1) scaling up ART; (2)
reforming procurement to reduce unit costs for drugs and
diagnostics; (3) sustaining prevention programs for key
populations and further enhancing coverage with strong
geographical prioritization; (4) establishing domestic
financing and management of community systems for prevention
and adherence support; and (5) strengthen integration with
other health, social and drug-use treatment programs. Bold
and immediate investment in the mentioned key programs and
measures to improve efficiency are needed to avoid large
increases in future health care cost and, most importantly,
prevent over 150,000 new infections and save over 110,000
lives by 2030. |
|---|